DA
LLY icon

Dover Advisors’s Eli Lilly LLY Stock Holding History

Dover Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
1,625
+20
+1% +$20.4K 0.72% 41
2026
Q1 		$1.48M Sell
1,605
-20
-1% -$20.3K 0.61% 45
2025
Q4 		$1.75M Buy
1,625
+93
+6% +$88.9K 0.68% 43
2025
Q3 		$1.17M Sell
1,532
-1
-0.1% -$744 0.47% 54
2025
Q2 		$1.2M Buy
1,533
+32
+2% +$24.9K 0.53% 51
2025
Q1 		$1.24M Sell
1,501
-33
-2% -$27.5K 0.54% 52
2024
Q4 		$1.18M Hold
1,534
– – 0.68% 50
2024
Q3 		$1.36M Sell
1,534
-13
-0.8% -$11.7K 0.77% 42
2024
Q2 		$1.4M Sell
1,547
-18
-1% -$14.4K 0.87% 36
2024
Q1 		$1.22M Buy
1,565
+120
+8% +$85.4K 0.83% 38
2023
Q4 		$842K Sell
1,445
-388
-21% -$226K 1.11% 31
2023
Q3 		$985K Sell
1,833
-8
-0.4% -$4.12K 1% 35
2023
Q2 		$863K Sell
1,841
-336
-15% -$141K 0.77% 44
2023
Q1 		$748K Buy
2,177
+340
+19% +$115K 0.72% 48
2022
Q4 		$672K Buy
+1,837
New +$651K 0.72% 49

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dover Advisors's LLY Position: Q2 2026 in Review

Dover Advisors increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $20.4K and bringing the position to 1,625 shares worth $1.75M. The position accounts for 0.72% of the portfolio, ranked #41.

Dover Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dover Advisors held 1,625 shares of Eli Lilly worth $1.75M as of Q2 2026.
  • Dover Advisors bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.72% of Dover Advisors's portfolio in Q2 2026, its #41 holding.
  • Dover Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dover Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.